EZZ
Director Trades
| Date | Director | Value |
|---|---|---|
| Q. Qin | $246,149 |
Company News
EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises
EZZ Life Science Holdings (ASX: EZZ) has engaged Australian-owned company ROFA Enterprises to distribute a minimum of $21 million in EZZ-branded products across three key markets in South-East Asia. The three-year non-exclusive agreement commenced this month and allows ROFA to sell the products across Thailand, Vietnam and Singapore. EZZ sees South-East Asia offering significant commercial […]
Market wrap: inflation pushes share prices lower on last trading day of the financial year
Inflation was the word on everybody’s lips as they dumped shares on the last trading day of the financial year but it was the price of goods and services rather than shares that had caught their attention. The week’s stunning news that inflation had reared back up to 4% for the year to May brought […]
EZZ Life Science eyes US market expansion after receiving FDA approval for nine products
EZZ Life Science Holdings (ASX: EZZ) has received approval for nine of its products in the food category from the US Food and Drug Administration (FDA). The EZZ-branded products are Children’s Essential Minerals, Children’s Eye Health, Bone Growth Chews, Brain Focus, Magnesium Plus, Aloe Vera Probiotic Capsules, Liver Detox, Joint Energy Boost Tablets and Men’s […]
EZZ Life Sciences posts strong financial performance for December quarter
Genomic life science company EZZ Life Science (ASX: EZZ) posted a strong financial performance for the three months to December 2022, with $8.6 million in customer cash receipts representing an increase of 43% on the previous quarter and 132% on the same period last year. The company attributed part of the result to the peak […]
EZZ Life Science continues sales momentum as trading on Douyin takes off
EZZ Life Science’s (ASX: EZZ) quarterly results for the period ended 30 September 2022 (Q1 FY2023) saw a significant rise in sales as a result of new product releases, and trading beginning on China’s Douyin e-commerce platform. The genomic life science company continued its strong sales momentum achieved in Q4 FY2022, closing Q1 FY2023 with […]
EZZ Life Science Holdings reports strong end to financial year
Despite significant market uncertainties bought on by the global lockdowns, EZZ Life Science Holdings (ASX: EZZ) has reported a strong end to the 2022 financial year. A diversification of distribution channels across Australia, New Zealand, China and other global markets led to a recovery in weak first-half revenues and combined with a strong cash balance […]
EZZ delivers strong FY2022 cash flow result despite tough start
EZZ Life Science (ASX: EZZ) has announced that despite a challenging start, it enjoyed a strong finish to the financial year ending June (FY2022) – placing it in a robust financial position for future growth. The genomic life science company said it had seen a “rapid recovery” in H2 FY2022 compared to H1 FY2021. FY2022 […]
EZZ continues to capitalise on growing skin care and health supplement markets across Asia Pacific
EZZ Life Science’s (ASX: EZZ) fourth quarter results (Q4 FY2022) have been highlighted by a rise in sales, with receipts from customers increasing 16% to $4.6 million compared to the previous quarter. The genomic life science company aims to improve the quality of life and human health through developing and selling products backed by genomic […]
Increased demand for EZZ’s hero products at China’s 618 shopping event
While China overcomes another period of COVID-19 related lockdowns and restrictions, its second largest annual e-commerce shopping event experienced more than 10% higher demand than last year’s event – with that demand flowing through to EZZ’s hero products. This year’s 618 shopping festival gave retailers a chance to recoup some of the sales lost to […]
Rising interest in ethically produced personal care and beauty markets across the globe
The market for ethically sourced and made health, well-being, beauty and personal care products has seen a spike in consumer interest in recent years, due to the COVID-19 pandemic and a growing preference for “clean-label”, vegan and “green” items. According to leading data and analytics company GlobalData, the Australian skincare market will rise from US$1.3 […]
